Combining three different sources of genetic information has allowed researchers to further understand why only some people with a common mutation go on to develop rare blood cancer.
The order in which genetic mutations are acquired determines how an individual cancer behaves, according to research from the University of Cambridge, published today in the New England Journal of Medicine.
The first comprehensive computer model to simulate the development of blood cells could help in the development of new treatments for leukaemia and lymphoma, say researchers at the University of Cambridge and Microsoft Research.
Researchers at the University of Cambridge, together with colleagues specialising in plastic surgery or histopathology in Austria, Australia, Liverpool and Swansea, have identified clues to explain how breast implants may, on very rare occasions, contribute to the development of lymphoma.
A new test for blood cancers will catch many more cases than the present test that identifies only 60 per cent.
A new test for blood cancers will catch many more cases than the present test that identifies only 60 per cent.
© 2024 University of Cambridge